All
Derm In The News: August 20-26
August 26th 2023Keep up with the latest headlines in dermatology from the past week, including growing concerns of a dermatologist shortage in Ontario, LEO Pharma's acquisition of Timber Pharmaceuticals, and more. This week, we have also included a patient-forward rundown of top headlines to share with your patients.
Frontline Forum Part 4: A Greater Understanding of the Acne Vulgaris Armamentarium
In the final part of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.
In Rosacea, Botulinum Toxin Requires Further Analysis of Long-Term Clinical Efficacy and Safety
August 23rd 2023While botulinum toxin has emerged as a treatment course for rosacea in recent years, researchers are calling for more comprehensive and detailed long-term research to assess its effectiveness.